Elucidating the precise pharmacological system of motion (MOA) of Obviously transpiring compounds could be challenging. Even though Tarselli et al. (sixty) developed the 1st de novo synthetic pathway to conolidine and showcased that this Normally occurring compound efficiently suppresses responses to both chemically induced and inflammation-derived